Other studies have confirmed that the age of CRC onset in carriers of MSH6 and PMS2 mutations was delayed by 10 years compared with carriers of MLH1 and MLH2 mutations with negligible risk before the age of 40 [58,60]. Here, PMS2 is linked to colorectal carcinoma.